Primary Recipient

ENDACEA, INC

Amount

$1,069,972.00

Award Date

9/01/2009

Administering Agency

Health and Human Services, Department of / National Institutes of Health

CDFA Number

93.701

CDFA Program Title

Trans-NIH Recovery Act Research Support

Description

Despite the availability of newer antimicrobial agents, improved supportive care, and the introduction of an FDA approved adjunctive therapy for sepsis, (Xigris(r), drotrecogin alfa), the mortality rate for severe sepsis and septic shock of 30-60% remains

Recipients Connected to Award

Recipient	Role	Amount
ENDACEA, INC	Primary recipient	$609,126.00
SAINT LOUIS UNIVERSITY	Sub-recipient	$460,846.00